Public signalCompany raiseAuto-indexed · Unverified
SYNTIS BIO, INC. raised $25.0M
SYNTIS BIO, INC.· Boston, US· Biotechnology· Filed Jul 2, 2025
SYNTIS BIO, INC. reported raising capital. Based in Boston, MASSACHUSETTS, US. First sale reported 2025-06-17. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$25.0M
Confidence90%
On the record
- Location
- Boston, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $25.0M
- Target amount
- $26.5M
- Filing date
- Jul 2, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 24,983,429 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jul 2, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with SYNTIS BIO, INC.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record